Oncology & Cancer

Study validates therapy for aggressive bladder cancer

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...

Oncology & Cancer

Study tackles reducing bladder cancer recurrence

National and international guidelines call for administration of postoperative immediate chemotherapy to reduce recurrence of non-muscle invasive bladder cancer. Yet this is done in less than half of cases. A new study ...

Oncology & Cancer

Can you keep your bladder after bladder cancer strikes?

After being diagnosed with bladder cancer, some patients face an almost impossible decision—have their bladder removed or take a risk knowing that the cancer may be more likely to spread if the bladder is left intact.

page 2 from 8